QA: Entrada Therapeutics Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001689375_2026_Entrada_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001689375, Entrada Therapeutics Inc

  xvar xval
0 AssetsCurrent 306,252,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 7,313,000
3 remainder_Assets 63,813,000
4 LiabilitiesCurrent 24,451,000
5 LiabilitiesNoncurrent 46,794,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 44,171,711
9 ResearchAndDevelopmentExpense 196,280,170
10 remainder_Expenses 901,613
11 remainder_Revenues 55,999,770
12 remainder_NetIncome 12,485,288
13 remainder_ComprehensiveNetIncome 194,373
  yvar yval
0 Assets 377,378,000
1 Liabilities 71,245,000
2 Expenses 241,353,494
3 Revenues 55,999,770
4 StockholdersEquity 306,133,000
5 NetIncome -172,868,436
6 ComprehensiveNetIncome -172,771,250
7 BaseVar 379,327,962
8 EconomicCapitalRatiobeforeLimitedLiability 2.20
9 EconomicCapitalRatio 3.16

Edgar->Model Mapping

Feature Distribution

Change over Time